Nisa Investment Advisors, LLC Concert Pharmaceuticals, Inc. Transaction History

Nisa Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 18, 2021	SELL	$3.17 - $4.15 $2,884 - $3,776	-910 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$9.48 - $12.84 $948 - $1,284	100 Added 12.35%	910 $12,000
Q3 2020 Oct 20, 2020	SELL	$8.67 - $10.82 $2,774 - $3,462	-320 Reduced 28.32%	810 $8,000
Q2 2020 Jul 27, 2020	BUY	$7.8 - $11.52 $5,382 - $7,948	690 Added 156.82%	1,130 $11,000
Q1 2020 Apr 17, 2020	BUY	$5.98 - $13.09 $2,631 - $5,759	440 New	440 $4,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.